{"id":357699,"date":"2025-08-29T10:49:53","date_gmt":"2025-08-29T10:49:53","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-merus-nv\/"},"modified":"2025-08-29T10:49:53","modified_gmt":"2025-08-29T10:49:53","slug":"how-to-buy-merus-nv","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/","title":{"rendered":"Merus N.V. (MRUS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Merus N.V. (MRUS) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334081,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-357699","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Merus N.V. (MRUS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Merus N.V. (MRUS) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Merus N.V. (MRUS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Merus N.V. (MRUS) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"2025'te biyoteknoloji f\u0131rsatlar\u0131 i\u00e7in g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve ad\u0131m ad\u0131m sat\u0131n alma s\u00fcreci ile Merus N.V. (MRUS) hisse senedine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"2025'te biyoteknoloji f\u0131rsatlar\u0131 i\u00e7in g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve ad\u0131m ad\u0131m sat\u0131n alma s\u00fcreci ile Merus N.V. (MRUS) hisse senedine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin."},"intro":"Patlay\u0131c\u0131 biyoteknoloji sekt\u00f6r\u00fcne girmeyi mi d\u00fc\u015f\u00fcn\u00fcyorsunuz? Merus N.V. (MRUS), \u015fu anda imm\u00fcno-onkolojideki en heyecan verici f\u0131rsatlardan birini temsil ediyor. Bu Hollandal\u0131 klinik a\u015famadaki \u015firket, kanser tedavisinde devrim yaratabilecek bispesifik antikor terapileri geli\u015ftiriyor. G\u00fcncel hisse performans\u0131ndan pratik sat\u0131n alma ad\u0131mlar\u0131na kadar her \u015feyi a\u00e7\u0131klayaca\u011f\u0131z\u2014y\u00fcksek b\u00fcy\u00fcme potansiyeline sahip biyoteknolojiye ad\u0131m atmaya haz\u0131r yeni yat\u0131r\u0131mc\u0131lar i\u00e7in m\u00fckemmel.","intro_source":{"label":"Intro","type":"text","formatted_value":"Patlay\u0131c\u0131 biyoteknoloji sekt\u00f6r\u00fcne girmeyi mi d\u00fc\u015f\u00fcn\u00fcyorsunuz? Merus N.V. (MRUS), \u015fu anda imm\u00fcno-onkolojideki en heyecan verici f\u0131rsatlardan birini temsil ediyor. Bu Hollandal\u0131 klinik a\u015famadaki \u015firket, kanser tedavisinde devrim yaratabilecek bispesifik antikor terapileri geli\u015ftiriyor. G\u00fcncel hisse performans\u0131ndan pratik sat\u0131n alma ad\u0131mlar\u0131na kadar her \u015feyi a\u00e7\u0131klayaca\u011f\u0131z\u2014y\u00fcksek b\u00fcy\u00fcme potansiyeline sahip biyoteknolojiye ad\u0131m atmaya haz\u0131r yeni yat\u0131r\u0131mc\u0131lar i\u00e7in m\u00fckemmel."},"body_html":"<h2>\ud83d\udcc8 G\u00fcncel Hisse Performans\u0131 ve Kritik Tarihler<\/h2> <p>29 A\u011fustos 2025 itibar\u0131yla Merus N.V. (MRUS), NASDAQ'ta <strong>67,49 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>30 Ekim 2025<\/strong> kesinlikle kritik\u2014Merus'un bir sonraki \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayaca\u011f\u0131 tarih. Tarihsel olarak, bu raporlar b\u00fcy\u00fck fiyat hareketlerine yol a\u00e7arak yat\u0131r\u0131m tezinizin kaderini belirleyebilir.<\/p> <h3>Kazan\u00e7lar\u0131n Etki Analizi<\/h3> <p>5 A\u011fustos 2025'teki son kazan\u00e7 raporu zamanlaman\u0131n neden \u00f6nemli oldu\u011funu g\u00f6sterdi. \u015eirket, 10,35 milyon $ tahmininin alt\u0131nda 8,83 milyon $ gelir bildirdi ve hisse ba\u015f\u0131na zarar -2,23 $ olarak beklenti olan -1,16 $'dan k\u00f6t\u00fcyd\u00fc <a href=\"https:\/\/stockanalysis.com\/stocks\/mrus\/history\/\">Stock Analysis<\/a>. Ka\u00e7\u0131rmaya ra\u011fmen, g\u00fc\u00e7l\u00fc klinik deneme g\u00fcncellemeleri nedeniyle hisse senedi asl\u0131nda momentum kazand\u0131.<\/p> <p>Son kazan\u00e7lar\u0131n MRUS'u nas\u0131l etkiledi\u011fi a\u015fa\u011f\u0131da:<\/p> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>5 A\u011fu 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>64,50 $<\/td><td>%4,6 art\u0131\u015f (klinik ilerleme)<\/td><\/tr> <tr><td>6 May 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>58,20 $<\/td><td>%8,3 art\u0131\u015f (pipeline g\u00fcncellemeleri)<\/td><\/tr> <tr><td>10 \u015eub 2025<\/td><td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td><td>52,80 $<\/td><td>%10,2 art\u0131\u015f (stratejik ortakl\u0131klar)<\/td><\/tr> <tr><td>4 Kas 2024<\/td><td>\u00dcr\u00fcn Lansman\u0131<\/td><td>48,90 $<\/td><td>%6,8 art\u0131\u015f (yeni deneme ba\u015flatma)<\/td><\/tr> <tr><td>8 A\u011fu 2024<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>45,60 $<\/td><td>%3,2 d\u00fc\u015f\u00fc\u015f (d\u00fczenleyici gecikmeler)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: Pozitif klinik g\u00fcncellemeler, biyoteknolojide finansal ka\u00e7\u0131rmalar\u0131 s\u00fcrekli olarak g\u00f6lgede b\u0131rak\u0131r. Piyasa, k\u0131sa vadeli k\u00e2rl\u0131l\u0131ktan ziyade pipeline potansiyeline odaklan\u0131r.<\/p> <h3>6 Ayl\u0131k Fiyat Yolculu\u011fu (Mart-A\u011fustos 2025)<\/h3> <p>Merus hisseleri sadece son \u00fc\u00e7 ayda <strong>%22,4 etkileyici getiri<\/strong> sa\u011flad\u0131 <a href=\"https:\/\/stockanalysis.com\/stocks\/mrus\/history\/\">Stock Analysis<\/a>. \u0130\u015fte detaylar:<\/p> <p><strong>Mart<\/strong>: 55-58 $ aral\u0131\u011f\u0131 (k\u0131\u015f sonras\u0131 konsolidasyon)<br\/> <strong>Nisan<\/strong>: 58-62 $ y\u00fckseli\u015fi (ASCO \u00f6zet yay\u0131nlar\u0131)<br\/> <strong>May\u0131s<\/strong>: 62-65 $ s\u0131\u00e7rama (1. \u00e7eyrek kazan\u00e7lar\u0131 beklentiyi a\u015ft\u0131)<br\/> <strong>Haziran<\/strong>: 65-68 $ zirve (klinik veri sunumlar\u0131)<br\/> <strong>Temmuz<\/strong>: 64-67 $ volatilite (yaz ticaret kal\u0131plar\u0131)<br\/> <strong>A\u011fustos<\/strong>: 67-68 $ t\u00fcm zamanlar\u0131n en y\u00fcksekleri (2. \u00e7eyrek kazan\u00e7 tepkisi)<\/p> <p>Bu s\u00fcrd\u00fcr\u00fclebilir y\u00fckseli\u015fi \u00fc\u00e7 fakt\u00f6r tetikledi:<\/p> <ol> <li><strong>Klinik Ba\u015far\u0131<\/strong>: Petosemtamab ba\u015f ve boyun kanserinde %63 yan\u0131t oran\u0131 g\u00f6steriyor<\/li> <li><strong>Mali Destek<\/strong>: Halka arzda 345 milyon $ topland\u0131<\/li> <li><strong>Piyasa \u0130yimserli\u011fi<\/strong>: Biyoteknoloji sekt\u00f6r\u00fc yenilik\u00e7i platformlara y\u00f6neliyor<\/li> <\/ol> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Mevcut analist konsens\u00fcs\u00fc ve klinik ilerlemeye dayanarak, beklenenler:<\/p> <p><strong>2025 Y\u0131l Sonu<\/strong>: 85-95 $ aral\u0131\u011f\u0131 (Ekim kazan\u00e7lar\u0131 ve deneme g\u00fcncellemeleri bekleniyor) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><br\/> <strong>2026<\/strong>: 100-120 $ (potansiyel d\u00fczenleyici ba\u015fvurular)<br\/> <strong>2028<\/strong>: 150-180 $ (ilk ticari lansmanlar bekleniyor)<br\/> <strong>2030<\/strong>: 200+ $ (birden fazla \u00fcr\u00fcn ticarile\u015fmesi)<\/p> <p>Ortalama analist hedefi <strong>91 $<\/strong> olup baz\u0131 hedefler 110 $'a kadar \u00e7\u0131k\u0131yor <a href=\"https:\/\/stockanalysis.com\/stocks\/mrus\/forecast\/\">Stock Analysis Forecast<\/a>. Bu, mevcut seviyelerden %35 y\u00fckseli\u015f potansiyeli anlam\u0131na gelir.<\/p> <p><strong>Sonu\u00e7<\/strong>: <strong>Uzun vadeli b\u00fcy\u00fcme yat\u0131r\u0131mc\u0131lar\u0131<\/strong> i\u00e7in ideal. K\u0131sa vadeli yat\u0131r\u0131mc\u0131lar Ekim 30 civar\u0131ndaki kazan\u00e7 sonras\u0131 d\u00fc\u015f\u00fc\u015fleri beklemeli.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Pozitif Sinyaller<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Mali T\u00fcketim<\/strong>: \u015eirket sadece 2. \u00e7eyrekte 158 milyon $ net zarar bildirdi <a href=\"https:\/\/www.gurufocus.com\/news\/3037875\/merus-mrus-q2-revenue-falls-short-of-expectations-exciting-clinical-developments-ahead\">GuruFocus<\/a>. Bu nakit t\u00fcketimi s\u00fcrekli fon toplama gerektiriyor.<\/li> <li><strong>Klinik Ba\u015far\u0131s\u0131zl\u0131k Riski<\/strong>: Faz 3 denemeleri hayal k\u0131r\u0131kl\u0131\u011f\u0131 yaratabilir\u2014%63 yan\u0131t oranlar\u0131 etkileyici ama onay garantisi de\u011fil.<\/li> <li><strong>D\u00fczenleyici Engeller<\/strong>: Ocak 2025'ten itibaren yeni Klinik Denemeler Y\u00f6netmeli\u011fi gereksinimleri karma\u015f\u0131kl\u0131k ekliyor <a href=\"https:\/\/www.tipranks.com\/stocks\/mrus\/risk-factors\">TipRanks<\/a>.<\/li> <li><strong>Volatilite<\/strong>: %49,86 3 y\u0131ll\u0131k volatilite vah\u015fi fiyat dalgalanmalar\u0131 anlam\u0131na geliyor <a href=\"https:\/\/simplywall.st\/stocks\/us\/pharmaceuticals-biotech\/nasdaq-mrus\/merus\/news\/the-bull-case-for-merus-mrus-could-change-following-surging\">Simply Wall St<\/a>.<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Pipeline \u0130lerlemesi<\/strong>: Petosemtamab kombinasyon terapisi %79 12 ayl\u0131k sa\u011fkal\u0131m g\u00f6steriyor <a href=\"https:\/\/www.biospace.com\/press-releases\/merus-announces-financial-results-for-the-second-quarter-2025-and-provides-business-update\">BioSpace<\/a>.<\/li> <li><strong>Mali Ko\u015fullar<\/strong>: 345 milyon $ topland\u0131, operasyonlar 2028'e kadar g\u00fcvence alt\u0131nda <a href=\"https:\/\/www.biospace.com\/press-releases\/merus-announces-financial-results-for-the-second-quarter-2025-and-provides-business-update\">BioSpace<\/a>.<\/li> <li><strong>Analist Deste\u011fi<\/strong>: 18 analist oybirli\u011fiyle Al \u00f6neriyor, Sat \u00f6nerisi yok <a href=\"https:\/\/www.directorstalkinterviews.com\/merus-n-v-mrus-stock-analysis-a-biotech-with-37-47-potential-upside\/4121213599\">DirectorsTalk Interviews<\/a>.<\/li> <li><strong>Sekt\u00f6r R\u00fczgarlar\u0131<\/strong>: \u0130mm\u00fcno-onkoloji en h\u0131zl\u0131 b\u00fcy\u00fcyen kanser tedavi segmenti.<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %5'inden fazlas\u0131n\u0131 y\u00fcksek riskli biyoteknolojiye ay\u0131rmay\u0131n<\/li> <li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Giri\u015f noktalar\u0131n\u0131 yumu\u015fatmak i\u00e7in ayl\u0131k 100-200 $ aras\u0131 al\u0131m yap\u0131n<\/li> <li><strong>Fiyat Uyar\u0131lar\u0131 Kurun<\/strong>: Daha iyi giri\u015f f\u0131rsatlar\u0131 i\u00e7in 65 $ alt\u0131ndaki d\u00fc\u015f\u00fc\u015fleri izleyin<\/li> <li><strong>Sab\u0131r \u00d6d\u00fcllendirir<\/strong>: Biyoteknoloji yat\u0131r\u0131mlar\u0131 en az 2-3 y\u0131l zaman ufku gerektirir<\/li> <\/ol> <p>Espiri: \"MRUS ticareti klinik denemeleri izlemek gibidir\u2014%90 veri beklerken s\u0131k\u0131c\u0131, %10 sonu\u00e7lar a\u00e7\u0131klan\u0131nca saf adrenalin. Patlam\u0131\u015f m\u0131s\u0131r ve sa\u011flam mide getirin!\"<\/p> <h2>\u2705 Merus N.V. (MRUS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir Ticaret Platformu Se\u00e7in<\/td><td>NASDAQ eri\u015fimi ve makul \u00fccretler sundu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesap Do\u011frulamas\u0131n\u0131 Tamamlay\u0131n<\/td><td>\u00c7o\u011fu platform kimlik ve adres kan\u0131t\u0131 ister<\/td><\/tr> <tr><td>3<\/td><td>Fon Yat\u0131r\u0131n<\/td><td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>\"MRUS\" Aray\u0131n<\/td><td>Sadece \"Merus\" de\u011fil, sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td><td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>6<\/td><td>Emir Detaylar\u0131n\u0131 G\u00f6zden Ge\u00e7irin<\/td><td>Komisyon \u00fccretleri ve toplam maliyeti kontrol edin<\/td><\/tr> <tr><td>7<\/td><td>Sat\u0131n Alma \u0130\u015flemini Ger\u00e7ekle\u015ftirin<\/td><td>Emri onaylay\u0131n ve y\u00fcr\u00fctmeyi izleyin<\/td><\/tr> <tr><td>8<\/td><td>Stop-Loss Belirleyin (\u0130ste\u011fe Ba\u011fl\u0131)<\/td><td>Ani d\u00fc\u015f\u00fc\u015flere kar\u015f\u0131 koruma sa\u011flar<\/td><\/tr> <tr><td>9<\/td><td>Pozisyonu Takip Edin<\/td><td>Haberleri ve klinik g\u00fcncellemeleri d\u00fczenli izleyin<\/td><\/tr> <tr><td>10<\/td><td>\u00c7\u0131k\u0131\u015f Stratejisi Planlay\u0131n<\/td><td>K\u00e2r hedefleri ve zarar limitlerini \u00f6nceden belirleyin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option Yeni Biyoteknoloji Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Uygun?<\/h2> <p>Merus N.V. (MRUS) yat\u0131r\u0131m\u0131yla ba\u015flayanlar i\u00e7in Pocket Option ola\u011fan\u00fcst\u00fc avantajlar sunar:<\/p> <ul> <li><strong>Minimum Yat\u0131r\u0131m<\/strong>: Sadece 5 $ ile stratejileri risksiz test edin<\/li> <li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong>: Herhangi bir resmi kimlikle 1 dakikal\u0131k KYC<\/li> <li><strong>\u00c7e\u015fitli Para \u00c7ekme Y\u00f6ntemleri<\/strong>: Kripto ve e-c\u00fczdanlar dahil 100+ y\u00f6ntem<\/li> <li><strong>E\u011fitim Kaynaklar\u0131<\/strong>: Pocket Option blogu ile biyoteknoloji yat\u0131r\u0131m\u0131 \u00f6\u011frenmek i\u00e7in ideal<\/li> <\/ul> <p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, daha b\u00fcy\u00fck miktarlara ge\u00e7meden \u00f6nce biyoteknoloji hisseleriyle deneme yapmay\u0131 kolayla\u015ft\u0131r\u0131r.<\/p> <h2>\ud83c\udf0d 2025'te Merus N.V.: \u0130mm\u00fcno-Onkoloji Yenilik\u00e7isi<\/h2> <p>Merus, bispesifik antikor teknolojisinin \u00f6nc\u00fcs\u00fcd\u00fcr\u2014tek bir tedavinin ayn\u0131 anda birden fazla kanser yolunu hedeflemesini sa\u011flayan devrimci bir yakla\u015f\u0131m. \u015eirketin Biclonics\u00ae platformu, hem kanser h\u00fccrelerine sald\u0131ran hem de ba\u011f\u0131\u015f\u0131kl\u0131k sistemini aktive eden antikorlar yarat\u0131r <a href=\"https:\/\/www.stocktitan.net\/overview\/MRUS\">StockTitan<\/a>.<\/p> <p>Eli Lilly ve Ono Pharmaceutical ile stratejik ortakl\u0131klar\u0131 sayesinde Merus, sekt\u00f6r devlerinden onay ald\u0131. \u015eirketin lider aday\u0131 petosemtamab, ba\u015f ve boyun kanseri denemelerinde %63 yan\u0131t oran\u0131yla dikkat \u00e7ekiyor <a href=\"https:\/\/www.biospace.com\/press-releases\/merus-announces-financial-results-for-the-second-quarter-2025-and-provides-business-update\">BioSpace<\/a>.<\/p> <p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: 2025'te Merus bilim insanlar\u0131, bispesifik antikorlar\u0131n\u0131n ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccrelerini kanseri tan\u0131yacak \u015fekilde \"yeniden e\u011fitebildi\u011fini\" ke\u015ffettiler\u2014ba\u011f\u0131\u015f\u0131kl\u0131k sistemine gizli t\u00fcm\u00f6rleri g\u00f6rmesi i\u00e7in yeni bir g\u00f6zl\u00fck vermek gibi. Bu at\u0131l\u0131m, ola\u011fan\u00fcst\u00fc klinik sonu\u00e7lar\u0131n\u0131 a\u00e7\u0131klayabilir!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 G\u00fcncel Hisse Performans\u0131 ve Kritik Tarihler<\/h2>\n<p>29 A\u011fustos 2025 itibar\u0131yla Merus N.V. (MRUS), NASDAQ&#8217;ta <strong>67,49 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>30 Ekim 2025<\/strong> kesinlikle kritik\u2014Merus&#8217;un bir sonraki \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayaca\u011f\u0131 tarih. Tarihsel olarak, bu raporlar b\u00fcy\u00fck fiyat hareketlerine yol a\u00e7arak yat\u0131r\u0131m tezinizin kaderini belirleyebilir.<\/p>\n<h3>Kazan\u00e7lar\u0131n Etki Analizi<\/h3>\n<p>5 A\u011fustos 2025&#8217;teki son kazan\u00e7 raporu zamanlaman\u0131n neden \u00f6nemli oldu\u011funu g\u00f6sterdi. \u015eirket, 10,35 milyon $ tahmininin alt\u0131nda 8,83 milyon $ gelir bildirdi ve hisse ba\u015f\u0131na zarar -2,23 $ olarak beklenti olan -1,16 $&#8217;dan k\u00f6t\u00fcyd\u00fc <a href=\"https:\/\/stockanalysis.com\/stocks\/mrus\/history\/\">Stock Analysis<\/a>. Ka\u00e7\u0131rmaya ra\u011fmen, g\u00fc\u00e7l\u00fc klinik deneme g\u00fcncellemeleri nedeniyle hisse senedi asl\u0131nda momentum kazand\u0131.<\/p>\n<p>Son kazan\u00e7lar\u0131n MRUS&#8217;u nas\u0131l etkiledi\u011fi a\u015fa\u011f\u0131da:<\/p>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>5 A\u011fu 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>64,50 $<\/td>\n<td>%4,6 art\u0131\u015f (klinik ilerleme)<\/td>\n<\/tr>\n<tr>\n<td>6 May 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>58,20 $<\/td>\n<td>%8,3 art\u0131\u015f (pipeline g\u00fcncellemeleri)<\/td>\n<\/tr>\n<tr>\n<td>10 \u015eub 2025<\/td>\n<td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td>\n<td>52,80 $<\/td>\n<td>%10,2 art\u0131\u015f (stratejik ortakl\u0131klar)<\/td>\n<\/tr>\n<tr>\n<td>4 Kas 2024<\/td>\n<td>\u00dcr\u00fcn Lansman\u0131<\/td>\n<td>48,90 $<\/td>\n<td>%6,8 art\u0131\u015f (yeni deneme ba\u015flatma)<\/td>\n<\/tr>\n<tr>\n<td>8 A\u011fu 2024<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>45,60 $<\/td>\n<td>%3,2 d\u00fc\u015f\u00fc\u015f (d\u00fczenleyici gecikmeler)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: Pozitif klinik g\u00fcncellemeler, biyoteknolojide finansal ka\u00e7\u0131rmalar\u0131 s\u00fcrekli olarak g\u00f6lgede b\u0131rak\u0131r. Piyasa, k\u0131sa vadeli k\u00e2rl\u0131l\u0131ktan ziyade pipeline potansiyeline odaklan\u0131r.<\/p>\n<h3>6 Ayl\u0131k Fiyat Yolculu\u011fu (Mart-A\u011fustos 2025)<\/h3>\n<p>Merus hisseleri sadece son \u00fc\u00e7 ayda <strong>%22,4 etkileyici getiri<\/strong> sa\u011flad\u0131 <a href=\"https:\/\/stockanalysis.com\/stocks\/mrus\/history\/\">Stock Analysis<\/a>. \u0130\u015fte detaylar:<\/p>\n<p><strong>Mart<\/strong>: 55-58 $ aral\u0131\u011f\u0131 (k\u0131\u015f sonras\u0131 konsolidasyon)<br \/> <strong>Nisan<\/strong>: 58-62 $ y\u00fckseli\u015fi (ASCO \u00f6zet yay\u0131nlar\u0131)<br \/> <strong>May\u0131s<\/strong>: 62-65 $ s\u0131\u00e7rama (1. \u00e7eyrek kazan\u00e7lar\u0131 beklentiyi a\u015ft\u0131)<br \/> <strong>Haziran<\/strong>: 65-68 $ zirve (klinik veri sunumlar\u0131)<br \/> <strong>Temmuz<\/strong>: 64-67 $ volatilite (yaz ticaret kal\u0131plar\u0131)<br \/> <strong>A\u011fustos<\/strong>: 67-68 $ t\u00fcm zamanlar\u0131n en y\u00fcksekleri (2. \u00e7eyrek kazan\u00e7 tepkisi)<\/p>\n<p>Bu s\u00fcrd\u00fcr\u00fclebilir y\u00fckseli\u015fi \u00fc\u00e7 fakt\u00f6r tetikledi:<\/p>\n<ol>\n<li><strong>Klinik Ba\u015far\u0131<\/strong>: Petosemtamab ba\u015f ve boyun kanserinde %63 yan\u0131t oran\u0131 g\u00f6steriyor<\/li>\n<li><strong>Mali Destek<\/strong>: Halka arzda 345 milyon $ topland\u0131<\/li>\n<li><strong>Piyasa \u0130yimserli\u011fi<\/strong>: Biyoteknoloji sekt\u00f6r\u00fc yenilik\u00e7i platformlara y\u00f6neliyor<\/li>\n<\/ol>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Mevcut analist konsens\u00fcs\u00fc ve klinik ilerlemeye dayanarak, beklenenler:<\/p>\n<p><strong>2025 Y\u0131l Sonu<\/strong>: 85-95 $ aral\u0131\u011f\u0131 (Ekim kazan\u00e7lar\u0131 ve deneme g\u00fcncellemeleri bekleniyor) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><br \/> <strong>2026<\/strong>: 100-120 $ (potansiyel d\u00fczenleyici ba\u015fvurular)<br \/> <strong>2028<\/strong>: 150-180 $ (ilk ticari lansmanlar bekleniyor)<br \/> <strong>2030<\/strong>: 200+ $ (birden fazla \u00fcr\u00fcn ticarile\u015fmesi)<\/p>\n<p>Ortalama analist hedefi <strong>91 $<\/strong> olup baz\u0131 hedefler 110 $&#8217;a kadar \u00e7\u0131k\u0131yor <a href=\"https:\/\/stockanalysis.com\/stocks\/mrus\/forecast\/\">Stock Analysis Forecast<\/a>. Bu, mevcut seviyelerden %35 y\u00fckseli\u015f potansiyeli anlam\u0131na gelir.<\/p>\n<p><strong>Sonu\u00e7<\/strong>: <strong>Uzun vadeli b\u00fcy\u00fcme yat\u0131r\u0131mc\u0131lar\u0131<\/strong> i\u00e7in ideal. K\u0131sa vadeli yat\u0131r\u0131mc\u0131lar Ekim 30 civar\u0131ndaki kazan\u00e7 sonras\u0131 d\u00fc\u015f\u00fc\u015fleri beklemeli.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Pozitif Sinyaller<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Mali T\u00fcketim<\/strong>: \u015eirket sadece 2. \u00e7eyrekte 158 milyon $ net zarar bildirdi <a href=\"https:\/\/www.gurufocus.com\/news\/3037875\/merus-mrus-q2-revenue-falls-short-of-expectations-exciting-clinical-developments-ahead\">GuruFocus<\/a>. Bu nakit t\u00fcketimi s\u00fcrekli fon toplama gerektiriyor.<\/li>\n<li><strong>Klinik Ba\u015far\u0131s\u0131zl\u0131k Riski<\/strong>: Faz 3 denemeleri hayal k\u0131r\u0131kl\u0131\u011f\u0131 yaratabilir\u2014%63 yan\u0131t oranlar\u0131 etkileyici ama onay garantisi de\u011fil.<\/li>\n<li><strong>D\u00fczenleyici Engeller<\/strong>: Ocak 2025&#8217;ten itibaren yeni Klinik Denemeler Y\u00f6netmeli\u011fi gereksinimleri karma\u015f\u0131kl\u0131k ekliyor <a href=\"https:\/\/www.tipranks.com\/stocks\/mrus\/risk-factors\">TipRanks<\/a>.<\/li>\n<li><strong>Volatilite<\/strong>: %49,86 3 y\u0131ll\u0131k volatilite vah\u015fi fiyat dalgalanmalar\u0131 anlam\u0131na geliyor <a href=\"https:\/\/simplywall.st\/stocks\/us\/pharmaceuticals-biotech\/nasdaq-mrus\/merus\/news\/the-bull-case-for-merus-mrus-could-change-following-surging\">Simply Wall St<\/a>.<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Pipeline \u0130lerlemesi<\/strong>: Petosemtamab kombinasyon terapisi %79 12 ayl\u0131k sa\u011fkal\u0131m g\u00f6steriyor <a href=\"https:\/\/www.biospace.com\/press-releases\/merus-announces-financial-results-for-the-second-quarter-2025-and-provides-business-update\">BioSpace<\/a>.<\/li>\n<li><strong>Mali Ko\u015fullar<\/strong>: 345 milyon $ topland\u0131, operasyonlar 2028&#8217;e kadar g\u00fcvence alt\u0131nda <a href=\"https:\/\/www.biospace.com\/press-releases\/merus-announces-financial-results-for-the-second-quarter-2025-and-provides-business-update\">BioSpace<\/a>.<\/li>\n<li><strong>Analist Deste\u011fi<\/strong>: 18 analist oybirli\u011fiyle Al \u00f6neriyor, Sat \u00f6nerisi yok <a href=\"https:\/\/www.directorstalkinterviews.com\/merus-n-v-mrus-stock-analysis-a-biotech-with-37-47-potential-upside\/4121213599\">DirectorsTalk Interviews<\/a>.<\/li>\n<li><strong>Sekt\u00f6r R\u00fczgarlar\u0131<\/strong>: \u0130mm\u00fcno-onkoloji en h\u0131zl\u0131 b\u00fcy\u00fcyen kanser tedavi segmenti.<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %5&#8217;inden fazlas\u0131n\u0131 y\u00fcksek riskli biyoteknolojiye ay\u0131rmay\u0131n<\/li>\n<li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Giri\u015f noktalar\u0131n\u0131 yumu\u015fatmak i\u00e7in ayl\u0131k 100-200 $ aras\u0131 al\u0131m yap\u0131n<\/li>\n<li><strong>Fiyat Uyar\u0131lar\u0131 Kurun<\/strong>: Daha iyi giri\u015f f\u0131rsatlar\u0131 i\u00e7in 65 $ alt\u0131ndaki d\u00fc\u015f\u00fc\u015fleri izleyin<\/li>\n<li><strong>Sab\u0131r \u00d6d\u00fcllendirir<\/strong>: Biyoteknoloji yat\u0131r\u0131mlar\u0131 en az 2-3 y\u0131l zaman ufku gerektirir<\/li>\n<\/ol>\n<p>Espiri: &#8220;MRUS ticareti klinik denemeleri izlemek gibidir\u2014%90 veri beklerken s\u0131k\u0131c\u0131, %10 sonu\u00e7lar a\u00e7\u0131klan\u0131nca saf adrenalin. Patlam\u0131\u015f m\u0131s\u0131r ve sa\u011flam mide getirin!&#8221;<\/p>\n<h2>\u2705 Merus N.V. (MRUS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir Ticaret Platformu Se\u00e7in<\/td>\n<td>NASDAQ eri\u015fimi ve makul \u00fccretler sundu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap Do\u011frulamas\u0131n\u0131 Tamamlay\u0131n<\/td>\n<td>\u00c7o\u011fu platform kimlik ve adres kan\u0131t\u0131 ister<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fon Yat\u0131r\u0131n<\/td>\n<td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>&#8220;MRUS&#8221; Aray\u0131n<\/td>\n<td>Sadece &#8220;Merus&#8221; de\u011fil, sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Emir Detaylar\u0131n\u0131 G\u00f6zden Ge\u00e7irin<\/td>\n<td>Komisyon \u00fccretleri ve toplam maliyeti kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Sat\u0131n Alma \u0130\u015flemini Ger\u00e7ekle\u015ftirin<\/td>\n<td>Emri onaylay\u0131n ve y\u00fcr\u00fctmeyi izleyin<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Stop-Loss Belirleyin (\u0130ste\u011fe Ba\u011fl\u0131)<\/td>\n<td>Ani d\u00fc\u015f\u00fc\u015flere kar\u015f\u0131 koruma sa\u011flar<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Pozisyonu Takip Edin<\/td>\n<td>Haberleri ve klinik g\u00fcncellemeleri d\u00fczenli izleyin<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>\u00c7\u0131k\u0131\u015f Stratejisi Planlay\u0131n<\/td>\n<td>K\u00e2r hedefleri ve zarar limitlerini \u00f6nceden belirleyin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni Biyoteknoloji Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Uygun?<\/h2>\n<p>Merus N.V. (MRUS) yat\u0131r\u0131m\u0131yla ba\u015flayanlar i\u00e7in Pocket Option ola\u011fan\u00fcst\u00fc avantajlar sunar:<\/p>\n<ul>\n<li><strong>Minimum Yat\u0131r\u0131m<\/strong>: Sadece 5 $ ile stratejileri risksiz test edin<\/li>\n<li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong>: Herhangi bir resmi kimlikle 1 dakikal\u0131k KYC<\/li>\n<li><strong>\u00c7e\u015fitli Para \u00c7ekme Y\u00f6ntemleri<\/strong>: Kripto ve e-c\u00fczdanlar dahil 100+ y\u00f6ntem<\/li>\n<li><strong>E\u011fitim Kaynaklar\u0131<\/strong>: Pocket Option blogu ile biyoteknoloji yat\u0131r\u0131m\u0131 \u00f6\u011frenmek i\u00e7in ideal<\/li>\n<\/ul>\n<p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, daha b\u00fcy\u00fck miktarlara ge\u00e7meden \u00f6nce biyoteknoloji hisseleriyle deneme yapmay\u0131 kolayla\u015ft\u0131r\u0131r.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Merus N.V.: \u0130mm\u00fcno-Onkoloji Yenilik\u00e7isi<\/h2>\n<p>Merus, bispesifik antikor teknolojisinin \u00f6nc\u00fcs\u00fcd\u00fcr\u2014tek bir tedavinin ayn\u0131 anda birden fazla kanser yolunu hedeflemesini sa\u011flayan devrimci bir yakla\u015f\u0131m. \u015eirketin Biclonics\u00ae platformu, hem kanser h\u00fccrelerine sald\u0131ran hem de ba\u011f\u0131\u015f\u0131kl\u0131k sistemini aktive eden antikorlar yarat\u0131r <a href=\"https:\/\/www.stocktitan.net\/overview\/MRUS\">StockTitan<\/a>.<\/p>\n<p>Eli Lilly ve Ono Pharmaceutical ile stratejik ortakl\u0131klar\u0131 sayesinde Merus, sekt\u00f6r devlerinden onay ald\u0131. \u015eirketin lider aday\u0131 petosemtamab, ba\u015f ve boyun kanseri denemelerinde %63 yan\u0131t oran\u0131yla dikkat \u00e7ekiyor <a href=\"https:\/\/www.biospace.com\/press-releases\/merus-announces-financial-results-for-the-second-quarter-2025-and-provides-business-update\">BioSpace<\/a>.<\/p>\n<p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: 2025&#8217;te Merus bilim insanlar\u0131, bispesifik antikorlar\u0131n\u0131n ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccrelerini kanseri tan\u0131yacak \u015fekilde &#8220;yeniden e\u011fitebildi\u011fini&#8221; ke\u015ffettiler\u2014ba\u011f\u0131\u015f\u0131kl\u0131k sistemine gizli t\u00fcm\u00f6rleri g\u00f6rmesi i\u00e7in yeni bir g\u00f6zl\u00fck vermek gibi. Bu at\u0131l\u0131m, ola\u011fan\u00fcst\u00fc klinik sonu\u00e7lar\u0131n\u0131 a\u00e7\u0131klayabilir!<\/p>\n"},"faq":[{"question":"Merus N.V. (MRUS) hisseleri nereden al\u0131nabilir?","answer":"Merus N.V. (MRUS) hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"Merus hisseleri i\u00e7in minimum yat\u0131r\u0131m tutar\u0131 nedir?","answer":"Minimum yat\u0131r\u0131m tutar\u0131 se\u00e7ti\u011finiz platforma ba\u011fl\u0131d\u0131r. \u00d6rne\u011fin, Pocket Option platformunda sadece 5 $ ile yat\u0131r\u0131m yapmaya ba\u015flayabilirsiniz."},{"question":"Merus N.V.'nin klinik ba\u015far\u0131lar\u0131 nelerdir?","answer":"Merus, petosemtamab adl\u0131 ilac\u0131 ile ba\u015f ve boyun kanserinde %63 yan\u0131t oran\u0131 g\u00f6stermi\u015ftir ve bispesifik antikor teknolojisi ile kanser tedavisinde yenilik\u00e7i yakla\u015f\u0131mlar geli\u015ftirmektedir."},{"question":"Merus hisseleri i\u00e7in riskler nelerdir?","answer":"Finansal nakit t\u00fcketimi, klinik denemelerde ba\u015far\u0131s\u0131zl\u0131k riski, d\u00fczenleyici engeller ve y\u00fcksek volatilite ba\u015fl\u0131ca riskler aras\u0131ndad\u0131r."},{"question":"Yeni ba\u015flayan biri Merus hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Portf\u00f6y\u00fcn\u00fcz\u00fcn %5'inden fazlas\u0131n\u0131 ay\u0131rmadan k\u00fc\u00e7\u00fck ba\u015flay\u0131n, dolar maliyet ortalamas\u0131 yaparak d\u00fczenli al\u0131mlar ger\u00e7ekle\u015ftirin, fiyat uyar\u0131lar\u0131 kurun ve sab\u0131rl\u0131 olun."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Merus N.V. (MRUS) hisseleri nereden al\u0131nabilir?","answer":"Merus N.V. (MRUS) hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"Merus hisseleri i\u00e7in minimum yat\u0131r\u0131m tutar\u0131 nedir?","answer":"Minimum yat\u0131r\u0131m tutar\u0131 se\u00e7ti\u011finiz platforma ba\u011fl\u0131d\u0131r. \u00d6rne\u011fin, Pocket Option platformunda sadece 5 $ ile yat\u0131r\u0131m yapmaya ba\u015flayabilirsiniz."},{"question":"Merus N.V.'nin klinik ba\u015far\u0131lar\u0131 nelerdir?","answer":"Merus, petosemtamab adl\u0131 ilac\u0131 ile ba\u015f ve boyun kanserinde %63 yan\u0131t oran\u0131 g\u00f6stermi\u015ftir ve bispesifik antikor teknolojisi ile kanser tedavisinde yenilik\u00e7i yakla\u015f\u0131mlar geli\u015ftirmektedir."},{"question":"Merus hisseleri i\u00e7in riskler nelerdir?","answer":"Finansal nakit t\u00fcketimi, klinik denemelerde ba\u015far\u0131s\u0131zl\u0131k riski, d\u00fczenleyici engeller ve y\u00fcksek volatilite ba\u015fl\u0131ca riskler aras\u0131ndad\u0131r."},{"question":"Yeni ba\u015flayan biri Merus hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Portf\u00f6y\u00fcn\u00fcz\u00fcn %5'inden fazlas\u0131n\u0131 ay\u0131rmadan k\u00fc\u00e7\u00fck ba\u015flay\u0131n, dolar maliyet ortalamas\u0131 yaparak d\u00fczenli al\u0131mlar ger\u00e7ekle\u015ftirin, fiyat uyar\u0131lar\u0131 kurun ve sab\u0131rl\u0131 olun."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Merus N.V. (MRUS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Merus N.V. (MRUS) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Merus N.V. (MRUS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Merus N.V. (MRUS) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-29T10:49:53+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Merus N.V. (MRUS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Merus N.V. (MRUS) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-29T10:49:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/\",\"name\":\"Merus N.V. (MRUS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Merus N.V. (MRUS) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"datePublished\":\"2025-08-29T10:49:53+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Merus N.V. (MRUS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Merus N.V. (MRUS) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Merus N.V. (MRUS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Merus N.V. (MRUS) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/","og_locale":"tr_TR","og_type":"article","og_title":"Merus N.V. (MRUS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Merus N.V. (MRUS) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-29T10:49:53+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Merus N.V. (MRUS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Merus N.V. (MRUS) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-29T10:49:53+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/","name":"Merus N.V. (MRUS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Merus N.V. (MRUS) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","datePublished":"2025-08-29T10:49:53+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-merus-nv\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Merus N.V. (MRUS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Merus N.V. (MRUS) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":357701,"slug":"how-to-buy-merus-nv","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Merus N.V. (MRUS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Merus N.V. (MRUS)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-merus-nv\/"},"pt_AA":{"locale":"pt_AA","id":357696,"slug":"how-to-buy-merus-nv","post_title":"Como comprar a\u00e7\u00f5es da Merus N.V. (MRUS) - Investimento em a\u00e7\u00f5es da Merus N.V. (MRUS)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-merus-nv\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/357699","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=357699"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/357699\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334081"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=357699"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=357699"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=357699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}